Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves Article Swipe
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.3390/vaccines12050505
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into numerous lineages with unique spike mutations and caused multiple epidemics domestically and globally. Although COVID-19 vaccines are available, new variants with the capacity for immune evasion continue to emerge. To understand and characterize the evolution of circulating SARS-CoV-2 variants in the U.S., the Centers for Disease Control and Prevention (CDC) initiated the National SARS-CoV-2 Strain Surveillance (NS3) program and has received thousands of SARS-CoV-2 clinical specimens from across the nation as part of a genotype to phenotype characterization process. Focus reduction neutralization with various antisera was used to antigenically characterize 143 SARS-CoV-2 Delta, Mu and Omicron subvariants from selected clinical specimens received between May 2021 and February 2023, representing a total of 59 unique spike protein sequences. BA.4/5 subvariants BU.1, BQ.1.1, CR.1.1, CQ.2 and BA.4/5 + D420N + K444T; BA.2.75 subvariants BM.4.1.1, BA.2.75.2, CV.1; and recombinant Omicron variants XBF, XBB.1, XBB.1.5 showed the greatest escape from neutralizing antibodies when analyzed against post third-dose original monovalent vaccinee sera. Post fourth-dose bivalent vaccinee sera provided better protection against those subvariants, but substantial reductions in neutralization titers were still observed, especially among BA.4/5 subvariants with both an N-terminal domain (NTD) deletion and receptor binding domain (RBD) substitutions K444M + N460K and recombinant Omicron variants. This analysis demonstrated a framework for long-term systematic genotype to antigenic characterization of circulating and emerging SARS-CoV-2 variants in the U.S., which is critical to assessing their potential impact on the effectiveness of current vaccines and antigen recommendations for future updates.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3390/vaccines12050505
- https://www.mdpi.com/2076-393X/12/5/505/pdf?version=1715087649
- OA Status
- gold
- Cited By
- 4
- References
- 42
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4396707796
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4396707796Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3390/vaccines12050505Digital Object Identifier
- Title
-
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron WavesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-05-07Full publication date if available
- Authors
-
Han Di, Elizabeth A. Pusch, Joyce Jones, Nicholas A. Kovacs, Norman Hassell, Mili Sheth, Kelly Sabrina Lynn, Matthew W. Keller, Malania M. Wilson, Lisa M. Keong, Dan Cui, So Hee Park, Reina Chau, Kristine A. Lacek, Jimma Liddell, Marie K. Kirby, Genyan Yang, Monique Johnson, Sharmi Thor, Natosha Zanders, Chenchen Feng, Diya Surie, Jennifer DeCuir, Sandra Lester, Lydia J. Atherton, Heather Hicks, Azaibi Tamin, Jennifer L. Harcourt, Melissa M. Coughlin, Wesley H. Self, Jillian P. Rhoads, Kevin W. Gibbs, David N. Hager, Nathan I. Shapiro, Matthew C. Exline, Adam S. Lauring, Benjamin L. Rambo‐Martin, Clinton R. Paden, Rebecca Kondor, Justin S. Lee, John Barnes, Natalie J. Thornburg, Bin Zhou, David E. Wentworth, C. Todd DavisList of authors in order
- Landing page
-
https://doi.org/10.3390/vaccines12050505Publisher landing page
- PDF URL
-
https://www.mdpi.com/2076-393X/12/5/505/pdf?version=1715087649Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.mdpi.com/2076-393X/12/5/505/pdf?version=1715087649Direct OA link when available
- Concepts
-
Neutralization, Virology, Recombinant DNA, Titer, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Antibody, Biology, Genotype, Spike Protein, Neutralizing antibody, Antigen, Coronavirus disease 2019 (COVID-19), Immune system, Immunology, Medicine, Virus, Gene, Genetics, Infectious disease (medical specialty), Disease, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
4Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 2Per-year citation counts (last 5 years)
- References (count)
-
42Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4396707796 |
|---|---|
| doi | https://doi.org/10.3390/vaccines12050505 |
| ids.doi | https://doi.org/10.3390/vaccines12050505 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38793756 |
| ids.openalex | https://openalex.org/W4396707796 |
| fwci | 4.15244799 |
| type | article |
| title | Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves |
| biblio.issue | 5 |
| biblio.volume | 12 |
| biblio.last_page | 505 |
| biblio.first_page | 505 |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T10041 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9954000115394592 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | COVID-19 Clinical Research Studies |
| topics[2].id | https://openalex.org/T11754 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9954000115394592 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | SARS-CoV-2 detection and testing |
| is_xpac | False |
| apc_list.value | 2200 |
| apc_list.currency | CHF |
| apc_list.value_usd | 2382 |
| apc_paid.value | 2200 |
| apc_paid.currency | CHF |
| apc_paid.value_usd | 2382 |
| concepts[0].id | https://openalex.org/C14086860 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8168840408325195 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q337120 |
| concepts[0].display_name | Neutralization |
| concepts[1].id | https://openalex.org/C159047783 |
| concepts[1].level | 1 |
| concepts[1].score | 0.6920403242111206 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[1].display_name | Virology |
| concepts[2].id | https://openalex.org/C40767141 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6379535794258118 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q285697 |
| concepts[2].display_name | Recombinant DNA |
| concepts[3].id | https://openalex.org/C32611913 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6141476631164551 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2166189 |
| concepts[3].display_name | Titer |
| concepts[4].id | https://openalex.org/C3007834351 |
| concepts[4].level | 5 |
| concepts[4].score | 0.5453873872756958 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[4].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[5].id | https://openalex.org/C159654299 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5322005152702332 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[5].display_name | Antibody |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.4661620259284973 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C135763542 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4537140130996704 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q106016 |
| concepts[7].display_name | Genotype |
| concepts[8].id | https://openalex.org/C2909509916 |
| concepts[8].level | 5 |
| concepts[8].score | 0.4366682767868042 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q22329850 |
| concepts[8].display_name | Spike Protein |
| concepts[9].id | https://openalex.org/C2779261636 |
| concepts[9].level | 3 |
| concepts[9].score | 0.43625426292419434 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7003054 |
| concepts[9].display_name | Neutralizing antibody |
| concepts[10].id | https://openalex.org/C147483822 |
| concepts[10].level | 2 |
| concepts[10].score | 0.4321434497833252 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q103537 |
| concepts[10].display_name | Antigen |
| concepts[11].id | https://openalex.org/C3008058167 |
| concepts[11].level | 4 |
| concepts[11].score | 0.4236634075641632 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[11].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[12].id | https://openalex.org/C8891405 |
| concepts[12].level | 2 |
| concepts[12].score | 0.4150199294090271 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[12].display_name | Immune system |
| concepts[13].id | https://openalex.org/C203014093 |
| concepts[13].level | 1 |
| concepts[13].score | 0.3044106960296631 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[13].display_name | Immunology |
| concepts[14].id | https://openalex.org/C71924100 |
| concepts[14].level | 0 |
| concepts[14].score | 0.2927131652832031 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[14].display_name | Medicine |
| concepts[15].id | https://openalex.org/C2522874641 |
| concepts[15].level | 2 |
| concepts[15].score | 0.2837306261062622 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q808 |
| concepts[15].display_name | Virus |
| concepts[16].id | https://openalex.org/C104317684 |
| concepts[16].level | 2 |
| concepts[16].score | 0.2812907099723816 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[16].display_name | Gene |
| concepts[17].id | https://openalex.org/C54355233 |
| concepts[17].level | 1 |
| concepts[17].score | 0.2780892550945282 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[17].display_name | Genetics |
| concepts[18].id | https://openalex.org/C524204448 |
| concepts[18].level | 3 |
| concepts[18].score | 0.24556085467338562 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[18].display_name | Infectious disease (medical specialty) |
| concepts[19].id | https://openalex.org/C2779134260 |
| concepts[19].level | 2 |
| concepts[19].score | 0.21563255786895752 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[19].display_name | Disease |
| concepts[20].id | https://openalex.org/C142724271 |
| concepts[20].level | 1 |
| concepts[20].score | 0.0 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[20].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/neutralization |
| keywords[0].score | 0.8168840408325195 |
| keywords[0].display_name | Neutralization |
| keywords[1].id | https://openalex.org/keywords/virology |
| keywords[1].score | 0.6920403242111206 |
| keywords[1].display_name | Virology |
| keywords[2].id | https://openalex.org/keywords/recombinant-dna |
| keywords[2].score | 0.6379535794258118 |
| keywords[2].display_name | Recombinant DNA |
| keywords[3].id | https://openalex.org/keywords/titer |
| keywords[3].score | 0.6141476631164551 |
| keywords[3].display_name | Titer |
| keywords[4].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[4].score | 0.5453873872756958 |
| keywords[4].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[5].id | https://openalex.org/keywords/antibody |
| keywords[5].score | 0.5322005152702332 |
| keywords[5].display_name | Antibody |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.4661620259284973 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/genotype |
| keywords[7].score | 0.4537140130996704 |
| keywords[7].display_name | Genotype |
| keywords[8].id | https://openalex.org/keywords/spike-protein |
| keywords[8].score | 0.4366682767868042 |
| keywords[8].display_name | Spike Protein |
| keywords[9].id | https://openalex.org/keywords/neutralizing-antibody |
| keywords[9].score | 0.43625426292419434 |
| keywords[9].display_name | Neutralizing antibody |
| keywords[10].id | https://openalex.org/keywords/antigen |
| keywords[10].score | 0.4321434497833252 |
| keywords[10].display_name | Antigen |
| keywords[11].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[11].score | 0.4236634075641632 |
| keywords[11].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[12].id | https://openalex.org/keywords/immune-system |
| keywords[12].score | 0.4150199294090271 |
| keywords[12].display_name | Immune system |
| keywords[13].id | https://openalex.org/keywords/immunology |
| keywords[13].score | 0.3044106960296631 |
| keywords[13].display_name | Immunology |
| keywords[14].id | https://openalex.org/keywords/medicine |
| keywords[14].score | 0.2927131652832031 |
| keywords[14].display_name | Medicine |
| keywords[15].id | https://openalex.org/keywords/virus |
| keywords[15].score | 0.2837306261062622 |
| keywords[15].display_name | Virus |
| keywords[16].id | https://openalex.org/keywords/gene |
| keywords[16].score | 0.2812907099723816 |
| keywords[16].display_name | Gene |
| keywords[17].id | https://openalex.org/keywords/genetics |
| keywords[17].score | 0.2780892550945282 |
| keywords[17].display_name | Genetics |
| keywords[18].id | https://openalex.org/keywords/infectious-disease |
| keywords[18].score | 0.24556085467338562 |
| keywords[18].display_name | Infectious disease (medical specialty) |
| keywords[19].id | https://openalex.org/keywords/disease |
| keywords[19].score | 0.21563255786895752 |
| keywords[19].display_name | Disease |
| language | en |
| locations[0].id | doi:10.3390/vaccines12050505 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210226234 |
| locations[0].source.issn | 2076-393X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2076-393X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Vaccines |
| locations[0].source.host_organization | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_lineage_names | Multidisciplinary Digital Publishing Institute |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.mdpi.com/2076-393X/12/5/505/pdf?version=1715087649 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Vaccines |
| locations[0].landing_page_url | https://doi.org/10.3390/vaccines12050505 |
| locations[1].id | pmid:38793756 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Vaccines |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38793756 |
| locations[2].id | pmh:oai:doaj.org/article:e650ea20d08a473a8ce538057f6e9d59 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Vaccines, Vol 12, Iss 5, p 505 (2024) |
| locations[2].landing_page_url | https://doaj.org/article/e650ea20d08a473a8ce538057f6e9d59 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11125585 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Vaccines (Basel) |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11125585 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5109527006 |
| authorships[0].author.orcid | https://orcid.org/0009-0008-0672-1497 |
| authorships[0].author.display_name | Han Di |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[0].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[0].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[0].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[0].institutions[0].type | government |
| authorships[0].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Han Di |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[1].author.id | https://openalex.org/A5050492828 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8193-710X |
| authorships[1].author.display_name | Elizabeth A. Pusch |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[1].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[1].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[1].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Elizabeth A. Pusch |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[2].author.id | https://openalex.org/A5108496720 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Joyce Jones |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[2].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[2].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[2].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Joyce Jones |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[3].author.id | https://openalex.org/A5081645603 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5400-9316 |
| authorships[3].author.display_name | Nicholas A. Kovacs |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[3].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[3].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[3].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Nicholas A. Kovacs |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[4].author.id | https://openalex.org/A5078309976 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-0877-7992 |
| authorships[4].author.display_name | Norman Hassell |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[4].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[4].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[4].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Norman Hassell |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[5].author.id | https://openalex.org/A5073370603 |
| authorships[5].author.orcid | https://orcid.org/0009-0006-1488-6115 |
| authorships[5].author.display_name | Mili Sheth |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Core Laboratory Services and Response, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[5].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[5].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[5].institutions[0].type | government |
| authorships[5].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Mili Sheth |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Core Laboratory Services and Response, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[6].author.id | https://openalex.org/A5108927003 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Kelly Sabrina Lynn |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[6].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[6].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[6].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[6].institutions[0].type | government |
| authorships[6].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Kelly Sabrina Lynn |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[7].author.id | https://openalex.org/A5090062448 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-5850-1698 |
| authorships[7].author.display_name | Matthew W. Keller |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[7].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[7].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[7].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Matthew W. Keller |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[8].author.id | https://openalex.org/A5003038383 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-3486-1725 |
| authorships[8].author.display_name | Malania M. Wilson |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[8].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[8].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[8].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[8].institutions[0].type | government |
| authorships[8].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Malania M. Wilson |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[9].author.id | https://openalex.org/A5059734466 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-8211-659X |
| authorships[9].author.display_name | Lisa M. Keong |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[9].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[9].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[9].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[9].institutions[0].type | government |
| authorships[9].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Lisa M. Keong |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[10].author.id | https://openalex.org/A5076967625 |
| authorships[10].author.orcid | https://orcid.org/0009-0008-7100-8751 |
| authorships[10].author.display_name | Dan Cui |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[10].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[10].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[10].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[10].institutions[0].type | government |
| authorships[10].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Dan Cui |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[11].author.id | https://openalex.org/A5008230015 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-8751-2022 |
| authorships[11].author.display_name | So Hee Park |
| authorships[11].countries | US |
| authorships[11].affiliations[0].raw_affiliation_string | Eagle Global Scientific, Inc., Atlanta, GA 30341, USA |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I1289490764 |
| authorships[11].affiliations[1].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[11].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[11].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[11].institutions[0].type | government |
| authorships[11].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | So Hee Park |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA, Eagle Global Scientific, Inc., Atlanta, GA 30341, USA |
| authorships[12].author.id | https://openalex.org/A5066496869 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-3012-1404 |
| authorships[12].author.display_name | Reina Chau |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[12].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[12].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[12].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[12].institutions[0].type | government |
| authorships[12].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Reina Chau |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[13].author.id | https://openalex.org/A5058339232 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-6247-5082 |
| authorships[13].author.display_name | Kristine A. Lacek |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[13].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[13].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[13].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[13].institutions[0].type | government |
| authorships[13].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Kristine A. Lacek |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[14].author.id | https://openalex.org/A5009540061 |
| authorships[14].author.orcid | https://orcid.org/0009-0007-0226-5183 |
| authorships[14].author.display_name | Jimma Liddell |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[14].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[14].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[14].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[14].institutions[0].type | government |
| authorships[14].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Jimma D. Liddell |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[15].author.id | https://openalex.org/A5068689473 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-0859-9604 |
| authorships[15].author.display_name | Marie K. Kirby |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[15].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[15].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[15].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[15].institutions[0].type | government |
| authorships[15].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Marie K. Kirby |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[16].author.id | https://openalex.org/A5045558398 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-4631-6302 |
| authorships[16].author.display_name | Genyan Yang |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[16].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[16].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[16].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[16].institutions[0].type | government |
| authorships[16].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Genyan Yang |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[17].author.id | https://openalex.org/A5108097818 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Monique Johnson |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[17].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[17].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[17].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[17].institutions[0].type | government |
| authorships[17].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Monique Johnson |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[18].author.id | https://openalex.org/A5067446907 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-0234-5403 |
| authorships[18].author.display_name | Sharmi Thor |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[18].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[18].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[18].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[18].institutions[0].type | government |
| authorships[18].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Sharmi Thor |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[19].author.id | https://openalex.org/A5059799400 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Natosha Zanders |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[19].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[19].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[19].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[19].institutions[0].type | government |
| authorships[19].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Natosha Zanders |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[20].author.id | https://openalex.org/A5000051475 |
| authorships[20].author.orcid | |
| authorships[20].author.display_name | Chenchen Feng |
| authorships[20].countries | US |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[20].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[20].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[20].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[20].institutions[0].type | government |
| authorships[20].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[20].institutions[0].country_code | US |
| authorships[20].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Chenchen Feng |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[21].author.id | https://openalex.org/A5075720122 |
| authorships[21].author.orcid | https://orcid.org/0000-0003-3931-1423 |
| authorships[21].author.display_name | Diya Surie |
| authorships[21].countries | US |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[21].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[21].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[21].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[21].institutions[0].type | government |
| authorships[21].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[21].institutions[0].country_code | US |
| authorships[21].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Diya Surie |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[22].author.id | https://openalex.org/A5081608271 |
| authorships[22].author.orcid | https://orcid.org/0000-0001-5071-3875 |
| authorships[22].author.display_name | Jennifer DeCuir |
| authorships[22].countries | US |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[22].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[22].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[22].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[22].institutions[0].type | government |
| authorships[22].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[22].institutions[0].country_code | US |
| authorships[22].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Jennifer DeCuir |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[23].author.id | https://openalex.org/A5020414545 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-3829-365X |
| authorships[23].author.display_name | Sandra Lester |
| authorships[23].countries | US |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[23].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[23].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[23].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[23].institutions[0].type | government |
| authorships[23].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[23].institutions[0].country_code | US |
| authorships[23].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Sandra N. Lester |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[24].author.id | https://openalex.org/A5050982324 |
| authorships[24].author.orcid | https://orcid.org/0009-0005-5038-7092 |
| authorships[24].author.display_name | Lydia J. Atherton |
| authorships[24].countries | US |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[24].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[24].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[24].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[24].institutions[0].type | government |
| authorships[24].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[24].institutions[0].country_code | US |
| authorships[24].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Lydia Atherton |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[25].author.id | https://openalex.org/A5079831102 |
| authorships[25].author.orcid | |
| authorships[25].author.display_name | Heather Hicks |
| authorships[25].countries | US |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210099022 |
| authorships[25].affiliations[0].raw_affiliation_string | Synergy America, Inc., Duluth, GA 30329, USA |
| authorships[25].affiliations[1].institution_ids | https://openalex.org/I1289490764 |
| authorships[25].affiliations[1].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[25].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[25].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[25].institutions[0].type | government |
| authorships[25].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[25].institutions[0].country_code | US |
| authorships[25].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[25].institutions[1].id | https://openalex.org/I4210099022 |
| authorships[25].institutions[1].ror | https://ror.org/01t01fd32 |
| authorships[25].institutions[1].type | company |
| authorships[25].institutions[1].lineage | https://openalex.org/I4210099022 |
| authorships[25].institutions[1].country_code | US |
| authorships[25].institutions[1].display_name | Synergy America (United States) |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Heather Hicks |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA, Synergy America, Inc., Duluth, GA 30329, USA |
| authorships[26].author.id | https://openalex.org/A5045559166 |
| authorships[26].author.orcid | https://orcid.org/0000-0001-9726-8940 |
| authorships[26].author.display_name | Azaibi Tamin |
| authorships[26].countries | US |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[26].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[26].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[26].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[26].institutions[0].type | government |
| authorships[26].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[26].institutions[0].country_code | US |
| authorships[26].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Azaibi Tamin |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[27].author.id | https://openalex.org/A5037099923 |
| authorships[27].author.orcid | https://orcid.org/0000-0003-3271-4174 |
| authorships[27].author.display_name | Jennifer L. Harcourt |
| authorships[27].countries | US |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[27].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[27].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[27].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[27].institutions[0].type | government |
| authorships[27].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[27].institutions[0].country_code | US |
| authorships[27].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Jennifer L. Harcourt |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[28].author.id | https://openalex.org/A5040055432 |
| authorships[28].author.orcid | https://orcid.org/0000-0003-1843-6251 |
| authorships[28].author.display_name | Melissa M. Coughlin |
| authorships[28].countries | US |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[28].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[28].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[28].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[28].institutions[0].type | government |
| authorships[28].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[28].institutions[0].country_code | US |
| authorships[28].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Melissa M. Coughlin |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[29].author.id | https://openalex.org/A5038114338 |
| authorships[29].author.orcid | https://orcid.org/0000-0002-9300-3045 |
| authorships[29].author.display_name | Wesley H. Self |
| authorships[29].countries | US |
| authorships[29].affiliations[0].institution_ids | https://openalex.org/I901861585 |
| authorships[29].affiliations[0].raw_affiliation_string | Vanderbilt Institute for Clinical & Translational Research, Vanderbilt University Medical Center, Nashville, TN 37232, USA |
| authorships[29].institutions[0].id | https://openalex.org/I901861585 |
| authorships[29].institutions[0].ror | https://ror.org/05dq2gs74 |
| authorships[29].institutions[0].type | healthcare |
| authorships[29].institutions[0].lineage | https://openalex.org/I4210162197, https://openalex.org/I901861585 |
| authorships[29].institutions[0].country_code | US |
| authorships[29].institutions[0].display_name | Vanderbilt University Medical Center |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | Wesley H. Self |
| authorships[29].is_corresponding | False |
| authorships[29].raw_affiliation_strings | Vanderbilt Institute for Clinical & Translational Research, Vanderbilt University Medical Center, Nashville, TN 37232, USA |
| authorships[30].author.id | https://openalex.org/A5029762377 |
| authorships[30].author.orcid | |
| authorships[30].author.display_name | Jillian P. Rhoads |
| authorships[30].countries | US |
| authorships[30].affiliations[0].institution_ids | https://openalex.org/I901861585 |
| authorships[30].affiliations[0].raw_affiliation_string | Vanderbilt Institute for Clinical & Translational Research, Vanderbilt University Medical Center, Nashville, TN 37232, USA |
| authorships[30].institutions[0].id | https://openalex.org/I901861585 |
| authorships[30].institutions[0].ror | https://ror.org/05dq2gs74 |
| authorships[30].institutions[0].type | healthcare |
| authorships[30].institutions[0].lineage | https://openalex.org/I4210162197, https://openalex.org/I901861585 |
| authorships[30].institutions[0].country_code | US |
| authorships[30].institutions[0].display_name | Vanderbilt University Medical Center |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | Jillian P. Rhoads |
| authorships[30].is_corresponding | False |
| authorships[30].raw_affiliation_strings | Vanderbilt Institute for Clinical & Translational Research, Vanderbilt University Medical Center, Nashville, TN 37232, USA |
| authorships[31].author.id | https://openalex.org/A5043282790 |
| authorships[31].author.orcid | https://orcid.org/0000-0002-5272-2289 |
| authorships[31].author.display_name | Kevin W. Gibbs |
| authorships[31].countries | US |
| authorships[31].affiliations[0].institution_ids | https://openalex.org/I47251452 |
| authorships[31].affiliations[0].raw_affiliation_string | Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA |
| authorships[31].institutions[0].id | https://openalex.org/I47251452 |
| authorships[31].institutions[0].ror | https://ror.org/0207ad724 |
| authorships[31].institutions[0].type | education |
| authorships[31].institutions[0].lineage | https://openalex.org/I47251452 |
| authorships[31].institutions[0].country_code | US |
| authorships[31].institutions[0].display_name | Wake Forest University |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | Kevin W. Gibbs |
| authorships[31].is_corresponding | False |
| authorships[31].raw_affiliation_strings | Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA |
| authorships[32].author.id | https://openalex.org/A5047192284 |
| authorships[32].author.orcid | https://orcid.org/0000-0002-5148-4872 |
| authorships[32].author.display_name | David N. Hager |
| authorships[32].countries | US |
| authorships[32].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[32].affiliations[0].raw_affiliation_string | Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA |
| authorships[32].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[32].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[32].institutions[0].type | healthcare |
| authorships[32].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[32].institutions[0].country_code | US |
| authorships[32].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[32].institutions[1].id | https://openalex.org/I145311948 |
| authorships[32].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[32].institutions[1].type | education |
| authorships[32].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[32].institutions[1].country_code | US |
| authorships[32].institutions[1].display_name | Johns Hopkins University |
| authorships[32].author_position | middle |
| authorships[32].raw_author_name | David N. Hager |
| authorships[32].is_corresponding | False |
| authorships[32].raw_affiliation_strings | Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA |
| authorships[33].author.id | https://openalex.org/A5039748898 |
| authorships[33].author.orcid | https://orcid.org/0000-0003-3508-4390 |
| authorships[33].author.display_name | Nathan I. Shapiro |
| authorships[33].countries | US |
| authorships[33].affiliations[0].institution_ids | https://openalex.org/I1316535847 |
| authorships[33].affiliations[0].raw_affiliation_string | Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA |
| authorships[33].institutions[0].id | https://openalex.org/I1316535847 |
| authorships[33].institutions[0].ror | https://ror.org/04drvxt59 |
| authorships[33].institutions[0].type | healthcare |
| authorships[33].institutions[0].lineage | https://openalex.org/I1316535847 |
| authorships[33].institutions[0].country_code | US |
| authorships[33].institutions[0].display_name | Beth Israel Deaconess Medical Center |
| authorships[33].author_position | middle |
| authorships[33].raw_author_name | Nathan I. Shapiro |
| authorships[33].is_corresponding | False |
| authorships[33].raw_affiliation_strings | Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA |
| authorships[34].author.id | https://openalex.org/A5087672793 |
| authorships[34].author.orcid | https://orcid.org/0000-0001-6797-158X |
| authorships[34].author.display_name | Matthew C. Exline |
| authorships[34].countries | US |
| authorships[34].affiliations[0].institution_ids | https://openalex.org/I52357470 |
| authorships[34].affiliations[0].raw_affiliation_string | Department of Medicine, The Ohio State University, Columbus, OH 43210, USA |
| authorships[34].institutions[0].id | https://openalex.org/I52357470 |
| authorships[34].institutions[0].ror | https://ror.org/00rs6vg23 |
| authorships[34].institutions[0].type | education |
| authorships[34].institutions[0].lineage | https://openalex.org/I52357470 |
| authorships[34].institutions[0].country_code | US |
| authorships[34].institutions[0].display_name | The Ohio State University |
| authorships[34].author_position | middle |
| authorships[34].raw_author_name | Matthew C. Exline |
| authorships[34].is_corresponding | False |
| authorships[34].raw_affiliation_strings | Department of Medicine, The Ohio State University, Columbus, OH 43210, USA |
| authorships[35].author.id | https://openalex.org/A5047332848 |
| authorships[35].author.orcid | https://orcid.org/0000-0003-2906-8335 |
| authorships[35].author.display_name | Adam S. Lauring |
| authorships[35].countries | US |
| authorships[35].affiliations[0].institution_ids | https://openalex.org/I27837315 |
| authorships[35].affiliations[0].raw_affiliation_string | Departments of Internal Medicine and Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA |
| authorships[35].institutions[0].id | https://openalex.org/I27837315 |
| authorships[35].institutions[0].ror | https://ror.org/00jmfr291 |
| authorships[35].institutions[0].type | education |
| authorships[35].institutions[0].lineage | https://openalex.org/I27837315 |
| authorships[35].institutions[0].country_code | US |
| authorships[35].institutions[0].display_name | University of Michigan |
| authorships[35].author_position | middle |
| authorships[35].raw_author_name | Adam S. Lauring |
| authorships[35].is_corresponding | False |
| authorships[35].raw_affiliation_strings | Departments of Internal Medicine and Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA |
| authorships[36].author.id | https://openalex.org/A5017902557 |
| authorships[36].author.orcid | https://orcid.org/0000-0002-8591-3954 |
| authorships[36].author.display_name | Benjamin L. Rambo‐Martin |
| authorships[36].countries | US |
| authorships[36].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[36].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[36].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[36].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[36].institutions[0].type | government |
| authorships[36].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[36].institutions[0].country_code | US |
| authorships[36].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[36].author_position | middle |
| authorships[36].raw_author_name | Benjamin Rambo-Martin |
| authorships[36].is_corresponding | False |
| authorships[36].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[37].author.id | https://openalex.org/A5076503623 |
| authorships[37].author.orcid | https://orcid.org/0000-0001-8701-8948 |
| authorships[37].author.display_name | Clinton R. Paden |
| authorships[37].countries | US |
| authorships[37].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[37].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[37].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[37].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[37].institutions[0].type | government |
| authorships[37].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[37].institutions[0].country_code | US |
| authorships[37].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[37].author_position | middle |
| authorships[37].raw_author_name | Clinton R. Paden |
| authorships[37].is_corresponding | False |
| authorships[37].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[38].author.id | https://openalex.org/A5082648750 |
| authorships[38].author.orcid | https://orcid.org/0000-0002-2596-4282 |
| authorships[38].author.display_name | Rebecca Kondor |
| authorships[38].countries | US |
| authorships[38].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[38].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[38].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[38].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[38].institutions[0].type | government |
| authorships[38].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[38].institutions[0].country_code | US |
| authorships[38].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[38].author_position | middle |
| authorships[38].raw_author_name | Rebecca J. Kondor |
| authorships[38].is_corresponding | False |
| authorships[38].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[39].author.id | https://openalex.org/A5040659299 |
| authorships[39].author.orcid | |
| authorships[39].author.display_name | Justin S. Lee |
| authorships[39].countries | US |
| authorships[39].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[39].affiliations[0].raw_affiliation_string | Division of Core Laboratory Services and Response, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[39].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[39].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[39].institutions[0].type | government |
| authorships[39].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[39].institutions[0].country_code | US |
| authorships[39].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[39].author_position | middle |
| authorships[39].raw_author_name | Justin S. Lee |
| authorships[39].is_corresponding | False |
| authorships[39].raw_affiliation_strings | Division of Core Laboratory Services and Response, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[40].author.id | https://openalex.org/A5073262712 |
| authorships[40].author.orcid | https://orcid.org/0000-0002-5874-4411 |
| authorships[40].author.display_name | John Barnes |
| authorships[40].countries | US |
| authorships[40].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[40].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[40].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[40].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[40].institutions[0].type | government |
| authorships[40].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[40].institutions[0].country_code | US |
| authorships[40].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[40].author_position | middle |
| authorships[40].raw_author_name | John R. Barnes |
| authorships[40].is_corresponding | False |
| authorships[40].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[41].author.id | https://openalex.org/A5022396107 |
| authorships[41].author.orcid | https://orcid.org/0000-0003-3523-3616 |
| authorships[41].author.display_name | Natalie J. Thornburg |
| authorships[41].countries | US |
| authorships[41].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[41].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[41].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[41].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[41].institutions[0].type | government |
| authorships[41].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[41].institutions[0].country_code | US |
| authorships[41].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[41].author_position | middle |
| authorships[41].raw_author_name | Natalie J. Thornburg |
| authorships[41].is_corresponding | False |
| authorships[41].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[42].author.id | https://openalex.org/A5034630762 |
| authorships[42].author.orcid | https://orcid.org/0000-0002-1535-6283 |
| authorships[42].author.display_name | Bin Zhou |
| authorships[42].countries | US |
| authorships[42].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[42].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[42].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[42].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[42].institutions[0].type | government |
| authorships[42].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[42].institutions[0].country_code | US |
| authorships[42].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[42].author_position | middle |
| authorships[42].raw_author_name | Bin Zhou |
| authorships[42].is_corresponding | False |
| authorships[42].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[43].author.id | https://openalex.org/A5043374942 |
| authorships[43].author.orcid | https://orcid.org/0000-0002-5190-980X |
| authorships[43].author.display_name | David E. Wentworth |
| authorships[43].countries | US |
| authorships[43].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[43].affiliations[0].raw_affiliation_string | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[43].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[43].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[43].institutions[0].type | government |
| authorships[43].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[43].institutions[0].country_code | US |
| authorships[43].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[43].author_position | middle |
| authorships[43].raw_author_name | David E. Wentworth |
| authorships[43].is_corresponding | False |
| authorships[43].raw_affiliation_strings | Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[44].author.id | https://openalex.org/A5051589681 |
| authorships[44].author.orcid | https://orcid.org/0000-0002-1429-974X |
| authorships[44].author.display_name | C. Todd Davis |
| authorships[44].countries | US |
| authorships[44].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[44].affiliations[0].raw_affiliation_string | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| authorships[44].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[44].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[44].institutions[0].type | government |
| authorships[44].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[44].institutions[0].country_code | US |
| authorships[44].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[44].author_position | last |
| authorships[44].raw_author_name | Charles Todd Davis |
| authorships[44].is_corresponding | False |
| authorships[44].raw_affiliation_strings | Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.mdpi.com/2076-393X/12/5/505/pdf?version=1715087649 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W2531367888, https://openalex.org/W2996280882, https://openalex.org/W2312755390, https://openalex.org/W1545923077, https://openalex.org/W3133547117, https://openalex.org/W3133794453, https://openalex.org/W2309520848, https://openalex.org/W3110499570, https://openalex.org/W2093961711, https://openalex.org/W2437044700 |
| cited_by_count | 4 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 2 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3390/vaccines12050505 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210226234 |
| best_oa_location.source.issn | 2076-393X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2076-393X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Vaccines |
| best_oa_location.source.host_organization | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_lineage_names | Multidisciplinary Digital Publishing Institute |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.mdpi.com/2076-393X/12/5/505/pdf?version=1715087649 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Vaccines |
| best_oa_location.landing_page_url | https://doi.org/10.3390/vaccines12050505 |
| primary_location.id | doi:10.3390/vaccines12050505 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210226234 |
| primary_location.source.issn | 2076-393X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2076-393X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Vaccines |
| primary_location.source.host_organization | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_lineage_names | Multidisciplinary Digital Publishing Institute |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.mdpi.com/2076-393X/12/5/505/pdf?version=1715087649 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Vaccines |
| primary_location.landing_page_url | https://doi.org/10.3390/vaccines12050505 |
| publication_date | 2024-05-07 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3001897055, https://openalex.org/W3121365103, https://openalex.org/W3129399011, https://openalex.org/W3168034622, https://openalex.org/W4210960512, https://openalex.org/W3165441111, https://openalex.org/W3217313168, https://openalex.org/W3215827060, https://openalex.org/W4225691034, https://openalex.org/W4380872791, https://openalex.org/W4313647364, https://openalex.org/W4285993171, https://openalex.org/W4308668146, https://openalex.org/W4284989724, https://openalex.org/W4281298256, https://openalex.org/W3092403777, https://openalex.org/W4220807057, https://openalex.org/W4283026725, https://openalex.org/W4301394219, https://openalex.org/W3136616180, https://openalex.org/W3163313401, https://openalex.org/W4288067932, https://openalex.org/W3010955108, https://openalex.org/W4282028871, https://openalex.org/W3182094313, https://openalex.org/W6843647923, https://openalex.org/W4309686974, https://openalex.org/W4294739369, https://openalex.org/W3139036184, https://openalex.org/W4317369991, https://openalex.org/W4311359167, https://openalex.org/W4315631193, https://openalex.org/W4318017360, https://openalex.org/W4361195651, https://openalex.org/W4387495573, https://openalex.org/W4387581535, https://openalex.org/W4386700314, https://openalex.org/W4367838604, https://openalex.org/W4392761745, https://openalex.org/W4391934251, https://openalex.org/W4392550987, https://openalex.org/W4312019047 |
| referenced_works_count | 42 |
| abstract_inverted_index.+ | 135, 137, 205 |
| abstract_inverted_index.2 | 5 |
| abstract_inverted_index.a | 83, 119, 214 |
| abstract_inverted_index.59 | 122 |
| abstract_inverted_index.Mu | 103 |
| abstract_inverted_index.To | 39 |
| abstract_inverted_index.an | 193 |
| abstract_inverted_index.as | 80 |
| abstract_inverted_index.in | 49, 181, 229 |
| abstract_inverted_index.is | 233 |
| abstract_inverted_index.of | 45, 72, 82, 121, 223, 243 |
| abstract_inverted_index.on | 240 |
| abstract_inverted_index.to | 37, 85, 97, 220, 235 |
| abstract_inverted_index.143 | 100 |
| abstract_inverted_index.May | 113 |
| abstract_inverted_index.and | 16, 21, 41, 57, 68, 104, 115, 133, 144, 198, 207, 225, 246 |
| abstract_inverted_index.are | 26 |
| abstract_inverted_index.but | 178 |
| abstract_inverted_index.for | 33, 54, 216, 249 |
| abstract_inverted_index.has | 7, 69 |
| abstract_inverted_index.new | 28 |
| abstract_inverted_index.the | 31, 43, 50, 52, 61, 78, 152, 230, 241 |
| abstract_inverted_index.was | 95 |
| abstract_inverted_index.2021 | 114 |
| abstract_inverted_index.CQ.2 | 132 |
| abstract_inverted_index.Post | 167 |
| abstract_inverted_index.This | 211 |
| abstract_inverted_index.XBF, | 148 |
| abstract_inverted_index.both | 192 |
| abstract_inverted_index.from | 76, 107, 155 |
| abstract_inverted_index.into | 9 |
| abstract_inverted_index.part | 81 |
| abstract_inverted_index.post | 161 |
| abstract_inverted_index.sera | 171 |
| abstract_inverted_index.used | 96 |
| abstract_inverted_index.were | 184 |
| abstract_inverted_index.when | 158 |
| abstract_inverted_index.with | 12, 30, 92, 191 |
| abstract_inverted_index.(CDC) | 59 |
| abstract_inverted_index.(NS3) | 66 |
| abstract_inverted_index.(NTD) | 196 |
| abstract_inverted_index.(RBD) | 202 |
| abstract_inverted_index.2023, | 117 |
| abstract_inverted_index.BU.1, | 129 |
| abstract_inverted_index.CV.1; | 143 |
| abstract_inverted_index.D420N | 136 |
| abstract_inverted_index.Focus | 89 |
| abstract_inverted_index.K444M | 204 |
| abstract_inverted_index.N460K | 206 |
| abstract_inverted_index.U.S., | 51, 231 |
| abstract_inverted_index.acute | 1 |
| abstract_inverted_index.among | 188 |
| abstract_inverted_index.sera. | 166 |
| abstract_inverted_index.spike | 14, 124 |
| abstract_inverted_index.still | 185 |
| abstract_inverted_index.their | 237 |
| abstract_inverted_index.those | 176 |
| abstract_inverted_index.total | 120 |
| abstract_inverted_index.which | 232 |
| abstract_inverted_index.BA.4/5 | 127, 134, 189 |
| abstract_inverted_index.Delta, | 102 |
| abstract_inverted_index.K444T; | 138 |
| abstract_inverted_index.Severe | 0 |
| abstract_inverted_index.Strain | 64 |
| abstract_inverted_index.XBB.1, | 149 |
| abstract_inverted_index.across | 77 |
| abstract_inverted_index.better | 173 |
| abstract_inverted_index.caused | 17 |
| abstract_inverted_index.domain | 195, 201 |
| abstract_inverted_index.escape | 154 |
| abstract_inverted_index.future | 250 |
| abstract_inverted_index.immune | 34 |
| abstract_inverted_index.impact | 239 |
| abstract_inverted_index.nation | 79 |
| abstract_inverted_index.showed | 151 |
| abstract_inverted_index.titers | 183 |
| abstract_inverted_index.unique | 13, 123 |
| abstract_inverted_index.BA.2.75 | 139 |
| abstract_inverted_index.BQ.1.1, | 130 |
| abstract_inverted_index.CR.1.1, | 131 |
| abstract_inverted_index.Centers | 53 |
| abstract_inverted_index.Control | 56 |
| abstract_inverted_index.Disease | 55 |
| abstract_inverted_index.Omicron | 105, 146, 209 |
| abstract_inverted_index.XBB.1.5 | 150 |
| abstract_inverted_index.against | 160, 175 |
| abstract_inverted_index.antigen | 247 |
| abstract_inverted_index.between | 112 |
| abstract_inverted_index.binding | 200 |
| abstract_inverted_index.current | 244 |
| abstract_inverted_index.emerge. | 38 |
| abstract_inverted_index.evasion | 35 |
| abstract_inverted_index.evolved | 8 |
| abstract_inverted_index.program | 67 |
| abstract_inverted_index.protein | 125 |
| abstract_inverted_index.various | 93 |
| abstract_inverted_index.Although | 23 |
| abstract_inverted_index.COVID-19 | 24 |
| abstract_inverted_index.February | 116 |
| abstract_inverted_index.National | 62 |
| abstract_inverted_index.analysis | 212 |
| abstract_inverted_index.analyzed | 159 |
| abstract_inverted_index.antisera | 94 |
| abstract_inverted_index.bivalent | 169 |
| abstract_inverted_index.capacity | 32 |
| abstract_inverted_index.clinical | 74, 109 |
| abstract_inverted_index.continue | 36 |
| abstract_inverted_index.critical | 234 |
| abstract_inverted_index.deletion | 197 |
| abstract_inverted_index.emerging | 226 |
| abstract_inverted_index.genotype | 84, 219 |
| abstract_inverted_index.greatest | 153 |
| abstract_inverted_index.lineages | 11 |
| abstract_inverted_index.multiple | 18 |
| abstract_inverted_index.numerous | 10 |
| abstract_inverted_index.original | 163 |
| abstract_inverted_index.process. | 88 |
| abstract_inverted_index.provided | 172 |
| abstract_inverted_index.received | 70, 111 |
| abstract_inverted_index.receptor | 199 |
| abstract_inverted_index.selected | 108 |
| abstract_inverted_index.syndrome | 3 |
| abstract_inverted_index.updates. | 251 |
| abstract_inverted_index.vaccinee | 165, 170 |
| abstract_inverted_index.vaccines | 25, 245 |
| abstract_inverted_index.variants | 29, 48, 147, 228 |
| abstract_inverted_index.BM.4.1.1, | 141 |
| abstract_inverted_index.antigenic | 221 |
| abstract_inverted_index.assessing | 236 |
| abstract_inverted_index.epidemics | 19 |
| abstract_inverted_index.evolution | 44 |
| abstract_inverted_index.framework | 215 |
| abstract_inverted_index.globally. | 22 |
| abstract_inverted_index.initiated | 60 |
| abstract_inverted_index.long-term | 217 |
| abstract_inverted_index.mutations | 15 |
| abstract_inverted_index.observed, | 186 |
| abstract_inverted_index.phenotype | 86 |
| abstract_inverted_index.potential | 238 |
| abstract_inverted_index.reduction | 90 |
| abstract_inverted_index.specimens | 75, 110 |
| abstract_inverted_index.thousands | 71 |
| abstract_inverted_index.variants. | 210 |
| abstract_inverted_index.BA.2.75.2, | 142 |
| abstract_inverted_index.N-terminal | 194 |
| abstract_inverted_index.Prevention | 58 |
| abstract_inverted_index.SARS-CoV-2 | 47, 63, 73, 101, 227 |
| abstract_inverted_index.antibodies | 157 |
| abstract_inverted_index.available, | 27 |
| abstract_inverted_index.especially | 187 |
| abstract_inverted_index.monovalent | 164 |
| abstract_inverted_index.protection | 174 |
| abstract_inverted_index.reductions | 180 |
| abstract_inverted_index.sequences. | 126 |
| abstract_inverted_index.systematic | 218 |
| abstract_inverted_index.third-dose | 162 |
| abstract_inverted_index.understand | 40 |
| abstract_inverted_index.circulating | 46, 224 |
| abstract_inverted_index.coronavirus | 4 |
| abstract_inverted_index.fourth-dose | 168 |
| abstract_inverted_index.recombinant | 145, 208 |
| abstract_inverted_index.respiratory | 2 |
| abstract_inverted_index.substantial | 179 |
| abstract_inverted_index.subvariants | 106, 128, 140, 190 |
| abstract_inverted_index.(SARS-CoV-2) | 6 |
| abstract_inverted_index.Surveillance | 65 |
| abstract_inverted_index.characterize | 42, 99 |
| abstract_inverted_index.demonstrated | 213 |
| abstract_inverted_index.domestically | 20 |
| abstract_inverted_index.neutralizing | 156 |
| abstract_inverted_index.representing | 118 |
| abstract_inverted_index.subvariants, | 177 |
| abstract_inverted_index.antigenically | 98 |
| abstract_inverted_index.effectiveness | 242 |
| abstract_inverted_index.substitutions | 203 |
| abstract_inverted_index.neutralization | 91, 182 |
| abstract_inverted_index.recommendations | 248 |
| abstract_inverted_index.characterization | 87, 222 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 94 |
| corresponding_author_ids | https://openalex.org/A5109527006 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 45 |
| corresponding_institution_ids | https://openalex.org/I1289490764 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8500000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.85797624 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |